Bio-Rad Laboratories found using ticker (BIO) have now 4 analysts covering the stock. The analyst consensus points to a rating of ''Strong_Buy''. The target price ranges between 775 and 735 with the average target price sitting at 755. With the stocks previous close at 602.97 this would imply there is a potential upside of 25.2%. The day 50 moving average is 600.68 and the 200 day MA is 592.31. The company has a market cap of $17,796m. Visit the company website at: /> [stock_market_widget type="chart" symbol="BIO" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Bio-Rad Laboratories develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.